These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. New tissue bulking agent (polyacrylate polyalcohol) for treating vesicoureteral reflux: preliminary results in children. Ormaechea M; Ruiz E; Denes E; Gimenez F; Dénes FT; Moldes J; Amarante A; Pioner G; Dekermacher S; de Badiola F J Urol; 2010 Feb; 183(2):714-7. PubMed ID: 20022037 [TBL] [Abstract][Full Text] [Related]
32. Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children. Peters CA; Skoog SJ; Arant BS; Copp HL; Elder JS; Hudson RG; Khoury AE; Lorenzo AJ; Pohl HG; Shapiro E; Snodgrass WT; Diaz M J Urol; 2010 Sep; 184(3):1134-44. PubMed ID: 20650499 [TBL] [Abstract][Full Text] [Related]
33. Predicting early recurrent urinary tract infection in pretoilet trained children with vesicoureteral reflux. Yamazaki Y; Shiroyanagi Y; Matsuno D; Nishi M J Urol; 2009 Oct; 182(4 Suppl):1699-702. PubMed ID: 19692080 [TBL] [Abstract][Full Text] [Related]
34. Endoscopic trigonoplasty in pediatric patients with primary vesicoureteral reflux: preliminary report. Okamura K; Yamada Y; Tsuji Y; Sakakibara T; Kondo A; Ono Y; Ohshima S; Miyake K J Urol; 1996 Jul; 156(1):198-200. PubMed ID: 8648802 [TBL] [Abstract][Full Text] [Related]
35. Endoscopic treatment of moderate and high grade vesicoureteral reflux in infants using dextranomer/hyaluronic acid. Puri P; Mohanan N; Menezes M; Colhoun E J Urol; 2007 Oct; 178(4 Pt 2):1714-6; discussion 1717. PubMed ID: 17707016 [TBL] [Abstract][Full Text] [Related]
36. Outcome after discontinuing prophylactic antibiotics in children with persistent vesicoureteral reflux. Kitchens DM; Herndon A; Joseph DB J Urol; 2010 Oct; 184(4 Suppl):1594-7. PubMed ID: 20728116 [TBL] [Abstract][Full Text] [Related]
37. Endoscopic management of vesicoureteral reflux in women presenting with pyelonephritis. Okeke Z; Fromer D; Katz MH; Reiley EA; Hensle TW J Urol; 2006 Nov; 176(5):2219-21. PubMed ID: 17070296 [TBL] [Abstract][Full Text] [Related]
38. Endoscopic treatment of vesicoureteral reflux in patients with myelodysplasia. Yokoyama O; Ishiura Y; Seto C; Uchibayashi T; Ohkawa M J Urol; 1996 Jun; 155(6):1882-6. PubMed ID: 8618279 [TBL] [Abstract][Full Text] [Related]
39. The effect of location of the ureteric orifice on the efficacy of endoscopic injection to correct vesico-ureteric reflux. Yucel S; Ucar M; Guntekin E; Kukul E; Melikoglu M; Baykara M BJU Int; 2005 Jun; 95(9):1314-8. PubMed ID: 15892824 [TBL] [Abstract][Full Text] [Related]
40. Can we rely on the presence of dextranomer-hyaluronic acid copolymer mounds on ultrasound to predict vesicoureteral reflux resolution after injection therapy? Zamilpa I; Koyle MA; Grady RW; Joyner BD; Shnorhavorian M; Lendvay TS J Urol; 2011 Jun; 185(6 Suppl):2536-41. PubMed ID: 21555031 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]